ASCPT SIGN IN
Username:
Password:
SEARCH

Member Spotlight

The ASCPT Member Spotlight is a forum to recognize and thank a member of ASCPT who has supported the Society's endeavors. We also highlight the Member of the Month, along with two other members, in each issue of Clinical Pharmacology & Therapeutics. We hope you will enjoy learning about fellow members and as always, encourage your participation in Society events and activities.

Sandra Visser, PhD: November Member Spotlight

Sandra A.G. Visser, PhD, Senior Director Clinical Pharmacology, GlaskoSmithKline, Clinical Pharmacology Modeling and Simulation, King of Prussia, PA

Dr. Visser learned about ASCPT during her PhD training and all of her years in industry, primarily through the journals and from colleagues who attended the ASCPT Meeting. However, she did not attend her first Annual Meeting until 2016. She was greatly surprised by the wealth of applied clinical and quantitative pharmacology content. She found the Meeting very interesting and tremendously inspiring with respect to having clinical pharmacology and therapeutics in focus. All of her Merck colleagues spoke highly of ASCPT and were active members, and provided positive encouragement to attend meetings and participate in committees.

The Annual Meeting has been a source of enjoyment and networking for Dr. Visser. She observes that the Networks are very active. At her first Meeting, she expressed a desire to volunteer. This led to her coleading the “Influence and Impact Initiative.” This initiative focuses on the education of the field on how quantitative pharmacology can enable decision-making in drug development and during therapeutic use. A collection of 37 case studies in the form of “1-sliders” have been released and can be used by any ASCPT member as an inspiration and an education tool. This crowd-sourced compendium of impactful case-examples is now available on the QP Network Page.

CPT, PSP, and CTS have shaped the field tremendously with high-impact publications, state-of-the-art articles, and themed issues. PSP also has advanced in podcast/virtual issues and other promotional activities. Also, Dr. Visser thinks that the working groups, networks, and committees are very high quality.

As for the younger generation of researchers and scientists, Dr. Visser encourages them to let the organizers and network leaders know about their interest in supporting the Society. Then when one is able to take part in a volunteering opportunity, be sure to make the most of it by being active: “speak up and engage.” She advises that “one thing easily leads to another if one contributes.”

At the end of the day, Dr. Visser believes that most in the field focus on getting better medicines to patients and on understanding how to make a difference. Quantitative pharmacology can help make drug development more rational and more efficient, and can also help individualize or optimize dosing during therapeutic use. The drivers for this are laid out in the recent white paper on model-informed drug discovery and therapeutic use.*

Over the last years, Dr. Visser has been part of the EFPIA MID3 working group. Recently, this group published the above white paper in PSP along with an accompanying podcast (both available online at www.psp-journal.com). This comprehensive paper illustrates her interest and ambition in terms of strategic direction for drug development and therapeutic use: i.e., to accelerate/increase efficiency and increase confidence using the integration of knowledge to further enhance development of new medicines. Her new role at GSK will be focusing on implementing this.

Dr. Visser has been a member of ASCPT since 2015. She currently serves on the Scientific Program Committee and is a member of the PSP Editorial Board. She recently served on the QP Influence and Impact Initiative.

Thank you, Dr. Visser, for your continued commitment to ASCPT and the discipline of clinical pharmacology and translational medicine.

*“Good Practices in Model-Informed Drug Discovery and Development: Practice Application and Documentation.” CPT: Pharmacometrics & Systems Pharmacology, Volume 5, Issue 3, Version of Record online: March 14 2016.
   
Previous Members of the Month
December 2016: Jasmine Davda, PhD
January 2017: Captain E. Dennis Bashaw, PharmD
February 2017: Shruti Agrawal, PhD
March 2017: Richard J. Bertz, PhD
April 2017: David M. Benjamin, PhD
May 2017: Albert J. Azzaro, PhD
June 2017: Guy-Armel Bounda, BSc, MSc, PhD
July 2017: Andrea Leigh Hahn, MD
August 2017: Sharvari Bhagwat, PhD
September 2017: Aline B. Barth, PhD
October 2017: Liang-Hui Chu, PhD
November 2017: Sandra Visser, PhD
528 N Washington St, Alexandria, VA 22314 |  Ph: 703.836.6981 |  info@ascpt.org